glp-1 agonists: Resmetirom and agonists for MASH: complementary rather than exclusive Top GLP-1 Agonists Balance Weight

Certain foods have been identified as potential GLP-1 boosters, offering a more holistic approach to managing appetite and blood sugar levels

The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.

Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins

Glucose-dependent insulinotropic polypeptide (GIP) is secreted by enteroendocrine K cells, primarily located in the upper small intestine, in response to food intake and plays a significant role in the postprandial regulation of nutrient metabolism

Primary outcomes included changes in TTR, INR, and INR recheck frequency

Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive